2 3 4 5 6 Formulation design Manufacturing process design Virtual patient population (PBPK, PDPK) API physical properties Dosage parameters Target.

Slides:



Advertisements
Similar presentations
Dr. Birgit Schmauser, BfArM, Bonn
Advertisements

Topical Bioequivalence Update Robert Lionberger, Ph.D. Office of Generic Drugs.
Dynamic model of a drop shot from an inkjet printer.
By Timina Olive Kayaviri Supervisor : Dr. Amugune
Methods of tablet manufacturing
Flow scheme of gas extraction from solids Chapter 3 Supercritical Fluid Extraction from Solids.
The NIPTE-FDA Excipients Database hosted at pharmaHUB Ann Christine Catlin Rosen Center for Advanced Computing Purdue University June 14, 2012.
1 MECH 221 FLUID MECHANICS (Fall 06/07) Tutorial 6 FLUID KINETMATICS.
Statistical variation of material properties In practice, material properties are seldom homogenous, as they are sensitive to variations in parameter such.
James Sprittles ECS 2007 Viscous Flow Over a Chemically Patterned Surface J.E. Sprittles Y.D. Shikhmurzaev.
TABLETS a mixture of powders compacted to form a single, rigid body most common dosage form possess a number of advantages B. AmsdenCHEE 440.
Kraft Pulping Modeling & Control 1 Control of Batch Kraft Digesters.
Particles in the Atmosphere CONTENTS 1. Introduction 2. Physical properties 3. Particle formation and growth 4. Chemical composition 5. Radiative properties.
PHUBpk: Pharmacokinetics on the pharmaHUB Stephen D. Stamatis 1, Michael J. McLennan 2, and Lee E. Kirsch 1 HUBbub The University of Iowa College.
Quality By Design and Dissolution PhRMA 10/25/05
Slide 1 May 2008 Training Workshop on Pharmaceutical Development with focus on Paediatric Formulations Mumbai, India Date: May 2008 QUALITY BY DESIGN.
Chemical Product Pyramid CHEMICAL PRODUCT ENGINEERING ASEP MUHAMAD SAMSUDIN.
Quality by Design Application of Pharmaceutical QbD for Enhancement of the Solubility and Dissolution of a Class II BCS Drug using Polymeric Surfactants.
ERT 420 BIOPHARMACEUTICAL ENGINEERING Semester 1 Academic Session 2012/2013 HUZAIRY HASSAN School Of Bioprocess Engineering Universiti Malaysia Perlis.
Title: Plan for Approach to the Understanding and Predicting Excipient Properties and Functionality NIPTE - National Institute of Pharmaceutical Technology.
Lecture Objectives Discuss specific class of problems
Applications of Analytical Chemistry in Pharmaceuticals Corey M. Chong 10Mar10.
OM: if PS is small, add diluent and use blend style Final Formulation: calculate capsule size, % excipients, and final formulation DF: choose excipients.
Dissolution and drug release testing
TransAT Tutorial Particle Tracking July 2015 ASCOMP
1-7.The ICH Q8 “Minimal Approach” to Pharmaceutical Development
Quality control Lecture 1.
Measure : SPC Dedy Sugiarto.
Critical Material Properties for Pharmaceutical Dosage Forms - Industry Perspective Tony Hlinak Abbott Laboratories North Chicago, IL.
MODELLING OF MULTIPHASE FLOWS OVER SURFACE WITH PENETRABLE ROUGH RELIEF Yevgeniy A. Shkvar National Aviation University, Kyiv, Ukraine
Excipient Composition and Performance-Related Properties of Excipients Chris Moreton, Ph.D. FinnBrit Consulting IPEC-Americas FDA Seminar, October 21,
Satish Mallya January 20-22, |1 | 2-3. Pharmaceutical Development Satish Mallya Quality Workshop, Copenhagen May 18-21, 2014 May 18-21,2014.
Global Microcrystalline Cellulose Market Future Market Insights
Formulation, Characterization of Pellets of Duloxetine Hydrochloride by Extrusion and Spheronization Prof. V. R. Sinha University Institute of Pharmaceutical.
Excipient Variability Sources, Importance and Potential Impact Chris Moreton, Ph.D Past Chair IPEC-Americas Partner – FinnBrit Consulting
Lattice Boltzmann Simulation of Fluid Flows M.J. Pattison & S. Banerjee MetaHeuristics LLC Santa Barbara, CA
CHEE 4401 Pathway of Absorption blood endothelium epithelium connective tissue, muscle.
Dr. Muslim Suardi, MSi., Apt. Faculty of Pharmacy, University of Andalas.
CS Machine Learning Instance Based Learning (Adapted from various sources)
Quality control Lecture 1.
1 Biopharmaceutics Dr Mohammad Issa Saleh. 2 Biopharmaceutics Biopharmaceutics is the science that examines this interrelationship of the physicochemical.
1.  It is defined in the regulations as “all products made of any materials of any nature to be used for the containment, protection, handling, delivery.
In vitro - In vivo Correlation
Integration of Excipients into the Design of Experiments for Pharmaceutical Product and Design Space Development Chris Moreton, Ph.D. FinnBrit Consulting.
Faculty of Pharmacy and Medical Sciences Al-Ahliyya Amman University
Material Characterization and Control and Knowledge Management Considerations for Continuous Manufacturing with the Real-Time Release Material Characterization.
Proposal for a Manufacturing Classification System (MCS)
- Pharmaceutical Equivalence Study
Results and Discussion
Gastrointestinal Absorption: Role of the Dosage Form
Dissolution testing and in vitro in vivo correlation of conventional and SR preparations Formulation development and optimization is an ongoing process.
TIMERx Oral Controlled-Release Drug Delivery System
Biopharmaceutic Considerations in Drug Product Design
IPSA (Industrial Problem Solving Ability )
Lecture Objectives Learn about particle dynamics modeling
@ 2016 Global Market Insight, Inc. USA. All Rights Reservedwww.fractovia.org Microcrystalline Cellulose Market PDF Report; Product Analysis, Size, Industry.
Instance Based Learning (Adapted from various sources)
Biopharmaceutics Dr Mohammad Issa Saleh.
Dimensional Analysis in Mass Transfer
Quality control Lecture 1.
Orientation to Pharmacology
Clinical Pharmacokinetics
Tablet Dosage Form Lab 1.
Drug Delivery Systems Pharmaceutical technology Petra University.
Biopharmaceutics 4th year
Micrometrics. It is the science and technology of small particles. Knowledge and control of the size and the size range of particles are of significant.
Tablets Lecturer: dr. Asmaa abdelaziz Mohamed Faculty of pharamcay
POWDER AND GRANULES FADHILAH FAIROZA FATIN HUSNA
Quality control Lecture 1.
RingCap Technology Mrs. Maria Saifee Associate Professor,
Presentation transcript:

2

3

4

5

6 Formulation design Manufacturing process design Virtual patient population (PBPK, PDPK) API physical properties Dosage parameters Target release profile Manufacturing parameters Dosage regimen Patient population parameters Pharmacokinetic, pharmacodynamic response prediction Target vs predicted API release profile prediction Drug (API) Design modification logic

7

8

9 ManufacturesGrades Particle Size, µm Moisture, % Loose Bulk Density, g/cc FMCAvicel PH JRS Vivapur Emcocel 50M AKC PH UF KG KG FMCAvicel PH JRS Vivapur Emcocel 90M AKCPH FMC = FMC BIOPOLYMERS AKC = Asahi Kasei Corporation JRS = J Rettenmaier & Söhne GmbH and Co.KG

10 40 data points from 9 sources E 0 : mean = 7.1 GPa stdev = 1.9 GPa rsd = 0.27 Variation due to natural variation, testing method, other? Need standardized, trustworthy source of data.

11 Excipients - MCC Products - PH101 Lots - Lot # 1 Properties - particle size Test method - Light scattering Equipment - Malvern ← USP compendial category ← Actual product on the market

12 Catalog of properties and measurements Raw data, chemical & test descriptions Measurement presentation of data Derived from raw data e.g., particle size, histogram Tools for usage e.g., how to ID excipients to solve problems User Interface

13

14

15

16

17

18

19 2 components 9% active 2 components 30% active 3 components 9% active, 2% additive

20 Void Structure

21

22 Density variations in a tablet due to processing conditions (friction). PROCESS Flow around tablet (2-D approx.) ENVIRONMENT Simulation of erosion and dissolution considering the heterogeneous density distribution + Effects of FLOW Drug Release profile PERFORMANCE X-ray CT

23

24 Tablet represented on Cartesian grid Each cell is assigned: o Number and size of particles o Active particle dissolution coefficient o Solvent penetration coefficient o Distance to nearest tablet surface Values assigned as simple concentrations radii and representative coefficients Tablet/Bulk fluid interface handled via level set Moving boundary conditions Erosion type can be o Uniform o Density based o Fluid-Shear influenced Simple depiction of solvent penetration over defined grid Pharmahub input gui for tablet dissolution

25

26

27

28

29

30

31